C. Bernard and U. , We wish to thank Pr Hou for help in the analysis of neuroanatomical data and Dr. N. Upton (Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline) for the generous gift of SB-334867, Preliminary results have been presented at the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS) and published in abstract form (

C. Anaclet, R. Parmentier, G. Guidon, C. Buda, J. Sastre et al., Respective role of histamine and orexin neurons in sleep-wake control, Sleep, vol.30, 2007.

L. Bayer, E. Eggermann, M. Serafin, B. Saint-mleux, D. Machard et al., Orexins (hypocretins) directly excite tuberomammillary neurons, European Journal of Neuroscience, vol.901, issue.9, pp.1571-1575, 2001.
DOI : 10.1046/j.0953-816x.2001.01777.x

R. Chemelli, J. Willie, C. Sinton, J. Elmquist, T. Scammell et al., Narcolepsy in orexin Knockout Mice, Cell, vol.98, issue.4, pp.437-451, 1999.
DOI : 10.1016/S0092-8674(00)81973-X

L. De-lecea, T. Kilduff, C. Peyron, X. Gao, P. Foye et al., The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity, Proceedings of the National Academy of Sciences, vol.95, issue.1, pp.322-327, 1998.
DOI : 10.1073/pnas.95.1.322

M. Duxon, J. Stretton, K. Starr, D. Jones, V. Holland et al., Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX 1 ) receptors, with downstream 5-HT 2C receptor involvement, Psychopharmacology, vol.153, issue.2, pp.203-209, 2001.
DOI : 10.1007/s002130000550

K. Eriksson, O. Sergeeva, R. Brown, and H. Haas, Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus, J Neurosci, vol.21, pp.9273-9279, 2001.

R. Espana, S. Mccormack, T. Mochizuki, and T. Scammell, Running promotes wakefulness and increases cataplexy in orexin knockout mice, Sleep, vol.30, pp.1417-1425, 2007.

K. Franklin and G. Paxinos, The mouse brain in stereotaxic coordinates, 1997.

H. Haas and P. Panula, The role of histamine and the tuberomamillary nucleus in the nervous system, Nature Reviews Neuroscience, vol.346, issue.2, pp.121-130, 2003.
DOI : 10.1038/nrn1034

H. Haas, O. Sergeeva, and O. Selbach, Histamine in the Nervous System, Physiological Reviews, vol.88, issue.3, pp.1183-1242, 2008.
DOI : 10.1152/physrev.00043.2007

J. Hagan, R. Leslie, S. Patel, M. Evans, T. Wattam et al., Orexin A activates locus coeruleus cell firing and increases arousal in the rat, Proceedings of the National Academy of Sciences, vol.96, issue.19, pp.10911-10916, 1999.
DOI : 10.1073/pnas.96.19.10911

Z. Huang, W. Qu, W. Li, T. Mochizuki, N. Eguchi et al., Arousal effect of orexin A depends on activation of the histaminergic system, Proceedings of the National Academy of Sciences, vol.98, issue.17, pp.9965-9970, 2001.
DOI : 10.1073/pnas.181330998

J. John, M. Wu, L. Boehmer, and J. Siegel, Cataplexy-Active Neurons in the Hypothalamus, Neuron, vol.42, issue.4, pp.619-634, 2004.
DOI : 10.1016/S0896-6273(04)00247-8

D. Jones, J. Gartlon, F. Parker, S. Taylor, C. Routledge et al., Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity, Psychopharmacology, vol.153, issue.2, pp.210-218, 2001.
DOI : 10.1007/s002130000551

M. Lee, O. Hassani, and B. Jones, Discharge of Identified Orexin/Hypocretin Neurons across the Sleep-Waking Cycle, Journal of Neuroscience, vol.25, issue.28, pp.6716-6720, 2005.
DOI : 10.1523/JNEUROSCI.1887-05.2005

X. Ligneau, J. Lin, G. Vanni-mercier, M. Jouvet, J. Muir et al., Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist, J Pharmacol Exp Ther, vol.287, pp.658-666, 1998.

X. Ligneau, L. Landais, D. Perrin, J. Piriou, M. Uguen et al., Brain histamine and schizophrenia: Potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649, Biochemical Pharmacology, vol.73, issue.8, pp.1215-1224, 2007.
DOI : 10.1016/j.bcp.2007.01.023

URL : https://hal.archives-ouvertes.fr/inserm-00150117

F. Aniello, A. Rouleau, F. Gbahou, J. Arrang, C. Ganellin et al., BF2.649 1 -3-3-(4-Chlorophenyl)propoxy propyl piperidine, [ { [ ] } hydrochloride , a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology ], J Pharmacol Exp Ther, vol.320, pp.365-375, 2007.

J. Lin, PHYSIOLOGICAL REVIEW ARTICLE: Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons, Sleep Medicine Reviews, vol.4, issue.5, pp.471-503, 2000.
DOI : 10.1053/smrv.2000.0116

J. Lin, K. Sakai, and M. Jouvet, Evidence for histaminergic arousal mechanisms in the hypothalamus of cat, Neuropharmacology, vol.27, issue.2, pp.111-122, 1988.
DOI : 10.1016/0028-3908(88)90159-1

J. Lin, K. Sakai, G. Vanni-mercier, and M. Jouvet, A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats, Brain Research, vol.479, issue.2, pp.225-240, 1989.
DOI : 10.1016/0006-8993(89)91623-5

J. Lin, Y. Hou, K. Sakai, and M. Jouvet, Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat, JNeurosci, vol.16, pp.1523-1537, 1996.

J. Lin, Y. Dauvilliers, I. Arnulf, H. Bastuji, C. Anaclet et al., An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy: Studies in orexin???/??? mice and patients, Neurobiology of Disease, vol.30, issue.1, pp.74-83, 2008.
DOI : 10.1016/j.nbd.2007.12.003

URL : https://hal.archives-ouvertes.fr/inserm-00215993

L. Lin, J. Faraco, R. Li, H. Kadotani, R. W. Lin et al., The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene, Cell, vol.98, issue.3, pp.365-376, 1999.
DOI : 10.1016/S0092-8674(00)81965-0

L. Lin, J. Wisor, T. Shiba, S. Taheri, K. Yanai et al., Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background, Peptides, vol.23, issue.12, pp.2203-2211, 2002.
DOI : 10.1016/S0196-9781(02)00251-6

J. Marcus, C. Aschkenasi, C. Lee, R. Chemelli, C. Saper et al., Differential expression of orexin receptors 1 and 2 in the rat brain, The Journal of Comparative Neurology, vol.267, issue.1, 2001.
DOI : 10.1002/cne.1190

P. Martins, D. Almeida-'v, M. Pedrazzoli, L. Lin, E. Mignot et al., (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity, RegulPept, vol.1, issue.117, pp.155-158, 2004.

D. Mccormick, Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity, Progress in Neurobiology, vol.39, issue.4, pp.337-388, 1992.
DOI : 10.1016/0301-0082(92)90012-4

E. Mignot, . Editor, M. Kryger, T. Roth, and W. Dement, Narcolepsy: pharmacology, pathophysiology and genetics. Principles and Practice of Sleep Medicine, pp.761-779, 2005.
DOI : 10.1016/b0-72-160797-7/50071-9

E. Mignot and S. Nishino, Emerging therapies in narcolepsy-cataplexy, Sleep, vol.28, pp.754-763, 2005.

B. Mileykovskiy, L. Kiyashchenko, and J. Siegel, Behavioral Correlates of Activity in Identified Hypocretin/Orexin Neurons, Neuron, vol.46, issue.5, pp.787-798, 2005.
DOI : 10.1016/j.neuron.2005.04.035

M. Modirrousta, L. Mainville, and B. Jones, Orexin and MCH neurons express c-Fos differently after sleep deprivation vs. recovery and bear different adrenergic receptors, European Journal of Neuroscience, vol.124, issue.10, 2005.
DOI : 10.1111/j.1460-9568.2005.04104.x

G. Moruzzi, The sleep-waking cycle, Ergeb Physiol, vol.64, pp.1-165, 1972.

A. Nicholson and B. Stone, Antihistamines: Impaired performance and the tendency to sleep, European Journal of Clinical Pharmacology, vol.18, issue.52, pp.27-32, 1986.
DOI : 10.1007/BF00614191

A. Nicholson, P. Pascoe, and B. Stone, Histaminergic systems and sleep, Neuropharmacology, vol.24, issue.3, pp.245-250, 1985.
DOI : 10.1016/0028-3908(85)90081-4

S. Nishino, N. Fujiki, B. Ripley, E. Sakurai, M. Kato et al., Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs, Neuroscience Letters, vol.313, issue.3, pp.125-128, 2001.
DOI : 10.1016/S0304-3940(01)02270-4

H. Ohtsu, S. Tanaka, T. Terui, Y. Hori, Y. Makabe-kobayashi et al., Mice lacking histidine decarboxylase exhibit abnormal mast cells, Mice lacking histidine decarboxylase exhibit abnormal mast cells, pp.53-56, 2001.
DOI : 10.1016/S0014-5793(01)02663-1

R. Parmentier, H. Ohtsu, Z. Djebbara-hannas, J. Valatx, T. Watanabe et al., Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control, J Neurosci, vol.22, pp.7695-7711, 2002.

R. Parmentier, C. Anaclet, C. Guhennec, E. Brousseau, D. Bricout et al., The brain H3-receptor as a novel therapeutic target for vigilance and sleep???wake disorders, Biochemical Pharmacology, vol.73, issue.8, pp.1157-1171, 2007.
DOI : 10.1016/j.bcp.2007.01.002

URL : https://hal.archives-ouvertes.fr/inserm-00150083

M. Passani, J. Lin, A. Hancock, S. Crochet, and P. Blandina, The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders, Trends in Pharmacological Sciences, vol.25, issue.12, pp.618-625, 2004.
DOI : 10.1016/j.tips.2004.10.003

K. Sakai, M. Mansari, J. Lin, J. Zhang, G. Vanni-mercier et al., The posterior hypothalamus in the regulation of wakefulness and paradoxical sleep. The Diphencephalon and Sleep, Mancia M , Marini G, pp.171-198, 1990.

T. Sakurai, The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness, Nature Reviews Neuroscience, vol.13, issue.3, pp.171-181, 2007.
DOI : 10.1038/nrn2092

T. Sakurai, A. Amemiya, M. Ishii, I. Matsuzaki, R. Chemelli et al., Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior, Cell, vol.92, issue.4, pp.573-585, 1998.
DOI : 10.1016/S0092-8674(00)80949-6

M. Sallanon, K. Sakai, C. Buda, M. Puymartin, and M. Jouvet, Increase of paradoxical sleep induced by microinjections of ibotenic acid into the ventrolateral part of the posterior hypothalamus in the cat, Arch Ital Biol, vol.126, pp.87-97, 1988.

M. Sallanon, M. Denoyer, K. Kitahama, C. Aubert, N. Gay et al., Long-lasting insomnia induced by preoptic neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat, Neuroscience, vol.32, issue.3, pp.669-683, 1989.
DOI : 10.1016/0306-4522(89)90289-3

J. Sastre, C. Buda, J. Lin, and M. Jouvet, Differential c-fos expression in the rhinencephalon and striatum after enhanced sleep-wake states in the cat, European Journal of Neuroscience, vol.1, issue.Suppl. 1, pp.1397-1410, 2000.
DOI : 10.1046/j.1460-9568.2000.00006.x

J. Schwartz, J. Arrang, M. Garbarg, H. Pollard, and M. Ruat, Histaminergic transmission in the mammalian brain, Physiol Rev, vol.71, pp.1-51, 1991.

D. Smart, C. Sabido-david, S. Brough, F. Jewitt, A. Johns et al., SB-334867-A: the first selective orexin-1 receptor antagonist, British Journal of Pharmacology, vol.18, issue.6, pp.1179-1182, 2001.
DOI : 10.1038/sj.bjp.0703953

E. Soffin, M. Evans, C. Gill, M. Harries, C. Benham et al., SB-334867-A antagonises orexin mediated excitation in the locus coeruleus, Neuropharmacology, vol.42, issue.1, 2002.
DOI : 10.1016/S0028-3908(01)00156-3

T. Steininger, M. Alam, H. Gong, R. Szymusiak, and D. Mcginty, Sleep???waking discharge of neurons in the posterior lateral hypothalamus of the albino rat, Brain Research, vol.840, issue.1-2, pp.138-147, 1999.
DOI : 10.1016/S0006-8993(99)01648-0

K. Takahashi, J. Lin, and K. Sakai, Neuronal Activity of Histaminergic Tuberomammillary Neurons During Wake-Sleep States in the Mouse, Journal of Neuroscience, vol.26, issue.40, pp.10292-10298, 2006.
DOI : 10.1523/JNEUROSCI.2341-06.2006

URL : https://hal.archives-ouvertes.fr/inserm-00408027

K. Takahashi, J. Lin, and K. Sakai, Neuronal activity of orexin and non-orexin waking-active neurons during wake???sleep states in the mouse, Neuroscience, vol.153, issue.3, pp.860-870, 2008.
DOI : 10.1016/j.neuroscience.2008.02.058

URL : https://hal.archives-ouvertes.fr/inserm-00383752

K. Takahashi, J. Lin, and K. Sakai, Characterization and mapping of sleep???waking specific neurons in the basal forebrain and preoptic hypothalamus in mice, Neuroscience, vol.161, issue.1, pp.269-92, 2009.
DOI : 10.1016/j.neuroscience.2009.02.075

URL : https://hal.archives-ouvertes.fr/inserm-00383292

P. Torterolo, J. Yamuy, S. Sampogna, F. Morales, and M. Chase, Hypothalamic neurons that contain hypocretin (orexin) express c-fos during active wakefulness and carbachol-induced active sleep, Sleep Res Online, vol.4, pp.25-32, 2001.
DOI : 10.1016/s0006-8993(00)02891-2

J. Valatx and R. Bugat, Facteurs g??n??tiques dans le d??terminisme du cycle veille-sommeil chez la souris, Brain Research, vol.69, issue.2, pp.315-330, 1974.
DOI : 10.1016/0006-8993(74)90009-2

J. Valdes, P. Farias, A. Ocampo-garces, N. Cortes, M. Seron-ferre et al., Arousal and differential Fos expression in histaminergic neurons of the ascending arousal system during a feeding-related motivated behaviour, European Journal of Neuroscience, vol.406, issue.7, pp.1931-1942, 2005.
DOI : 10.1111/j.1460-9568.2005.04013.x

G. Vanni-mercier, S. Gigout, G. Debilly, and J. Lin, Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats, Behavioural Brain Research, vol.144, issue.1-2, pp.227-241, 2003.
DOI : 10.1016/S0166-4328(03)00091-3

URL : https://hal.archives-ouvertes.fr/inserm-00408041